Market access to new anticancer medicines for children and adolescents with cancer in Europe-Reference-Cited by-同舟云学术

Market access to new anticancer medicines for children and adolescents with cancer in Europe

Published:2022-04 Issue: Volume:165 Page:146-153
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Schoot Reineke A.^ORCID,Otth Maria A.^ORCID,Frederix Gerardus W.J.,Leufkens Hubert G.M.,Vassal Gilles^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference15 articles.

1. Unequal access to newly registered cancer drugs leads to potential loss of life-years in Europe;Uyl-de Groot;Cancers,2020

2. Report European Commission. https://ec.europa.eu/health/sites/health/files/files/paediatrics/docs/2017_childrensmedicines_report_en.pdf. Accessed 18-08-2021.

3. External reference pricing for pharmaceuticals – a survey and literature review to describe best practises for countries with expanding healthcare coverage;Holtorf;Value Health Reg. Issues.,2019

4. Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?;Adkins;Clinicoecon Outcomes Res,2017

5. The quality of economic evaluations of ultra-orphan drugs in Europe – a systematic review;Schuller;Orphanet J Rare Dis,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Availability and Access to Orphan Drugs for Rare Cancers in Bulgaria: Analysis of Delays and Public Expenditures;Cancers;2024-04-12

2. Suitability of paediatric legislation beyond the USA and Europe: a qualitative study on access to paediatric medicines;BMJ Public Health;2024-02

3. Precision oncology medicines and the need for real world evidence acceptance in health technology assessment: Importance of patient involvement in sustainable healthcare;European Journal of Cancer;2023-11

4. Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2;Cancers;2023-07-22

5. Target therapy for high-risk neuroblastoma treatment: integration of regulatory and scientific tools is needed;Frontiers in Medicine;2023-07-14